New drugs show promise, and research finds value in vaccines, antivirals, exercise and probiotics.

While social isolation is known to be an important factor in increasing the risk of dementia in old age, animal testing has ...

In a major new finding almost a decade in the making, researchers at Harvard Medical School say they’ve found a key that may ...

This research offers hope. By finding brain diseases earlier, we might be able to slow them down or manage them better. If ...

New research builds on evidence that diet, certain brain training exercises and physical activity can delay the decline of ...

In further experiments using the mice, those with lithium-deficient brains developed more plaques than did animals with ...

In a provocative new study, Harvard Medical School scientists found that lithium, an element found in some foods and drinking ...

A Japanese health ministry panel on Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and US industry peer Biogen Inc., by 15 ...

NIH funding for research on Alzheimer’s and other forms of dementia has risen from $562 million in 2014 to $3.9 billion in 2024.

This is the moment to spend more money on research, not less. Right now, all over the world, researchers are collecting data about Alzheimer’s disease.

About 7 million U.S. residents aged 65 and older have Alzheimer’s, the nation’s seventh-leading cause of death. Given the cresting age wave, the number is expected to roughly double in the ...